Related Experiment Video
Updated: Apr 28, 2026

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
Dendrobium officinale polysaccharide relieves hepatointestinal damage induced by chronic arsenic exposure in chickens
Yan Liu1, Hong Geng2, Biqi Han2
1College of Life Sciences and Food Engineering, Inner Mongolia Minzu University, Tongliao 028000, China; College of Veterinary Medicine, Northeast Agricultural University, 600 Changjiang Road, Harbin 150030, China.
Abstract:
Arsenic is a toxic substance that can enter the body through diet, and even skin contact. Dendrobium officinale polysaccharide (DOP) is one of the main active components of Dendrobium officinale, which has antioxidant and anti-inflammatory effects. To specify DOP's protective role against arsenic-induced hepatointestinal damage in chickens, this study explored the potential target and mechanism of DOP in intestinal barrier injury based on network pharmacological analysis. A hepatointestinal injury model was established in 19-day-old chicks by orally taking 42 days of arsenic (34.7 mg/L NaAsO2) with water. The results showed that oral DOP (850 mg/kg) for 42 days alleviated arsenic-induced liver and intestinal injury, mainly manifested by decreased expression levels of α-smooth muscle actin in liver and correspondingly decreased expression levels of collagen I, while the content of hydroxyproline increased. The levels of intestinal nuclear factor kappa-B and tumor necrosis factor-α mRNA expression were decreased, while claudin 1, zonula occludens-1, and occludin in the ileum were increased, and the α diversity index of intestinal flora was recovered. In summary, our study suggests that DOP alleviates arsenic-induced intestinal inflammation and intestinal barrier damage by modulating the gut microbiota, thereby alleviating liver fibrosis and steatosis in chickens.
More Related Videos
Related Concept Videos
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Functions of the Gut Microbiota
Inflammatory Bowel Disease II: Ulcerative Colitis

